| Application no. and date | 15750138.8 (espacenet) (Federated) (European Patent Register), 20150805 | | Patent/reg. no. and date | DK/EP 3177608, 20190918 | | Publication date | 20170614 | | Priority no. and date | US 201462033679 P, 20140806 | | EP pub. no. and date |
EP 3177608 20170614 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | P81904627DK00E | | Inventor | LUZZIO, Michael Joseph, Novartis Institutes for BioMedical Research Inc.
250 Massachusetts Avenue
Cambridge, MA 02139, US,
PAPILLON, Julien, Novartis Institutes for BioMedical Research Inc.
250 Technology Square
Cambridge, MA 02139, US,
VISSER, Michael Scott, Novartis Institutes for BioMedical Research Inc.
250 Massachusetts Avenue
Cambridge, MA 02131, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/506 (2006.01) , A61P 31/04 (2006.01) , C07D 401/14 (2006.01) , C07D 413/14 (2006.01) | | Title | Proteinkinase-C-hæmmere og fremgangsmåder til anvendelse deraf | | Int. application no. | IB2015055951 | | Int. publication no. | WO2016020864 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
